VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
Globe Newswire•27/07/2026•07:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.